Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2006 2
2010 1
2011 1
2015 1
2016 1
2017 1
2018 4
2019 1
2020 1
2021 1
2022 1
2023 1
2024 7
2025 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

22 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and Safety of Obinutuzumab in Immune-Mediated Thrombotic Thrombocytopenic Purpura.
Weisinger J, Bouzid R, Fadlallah J, Barbet C, Provot F, Poullin P, Neel A, Marie M, Rieu V, Kanouni T, Moranne O, Azoulay E, Marjanovic Z, Corre E, Joly AC, Baylatry MT, Joly BS, Veyradier A, Coppo P; French National Center for Thrombotic Microangiopathies (CNR‐MAT). Weisinger J, et al. Among authors: joly ac. Am J Hematol. 2025 Feb;100(2):350-353. doi: 10.1002/ajh.27550. Epub 2024 Dec 12. Am J Hematol. 2025. PMID: 39668454 Free PMC article. No abstract available.
Impact of Clinical and Pharmacological Parameters on Faecal Microbiota Transplantation Outcome in Clostridioides difficile Infections: Results of a 5-Year French National Survey.
Benech N, Cassir N, Alric L, Barbut F, Batista R, Bleibtreu A, Briot T, Davido B, Galperine T, Joly AC, Kapel N, Melchior C, Mosca A, Nebbad B, Pigneur B, Schneider SM, Wasiak M, Scanzi J, Sokol H; French Faecal Transplant Group (GFTF). Benech N, et al. Among authors: joly ac. Aliment Pharmacol Ther. 2025 Jan;61(1):159-167. doi: 10.1111/apt.18330. Epub 2024 Oct 10. Aliment Pharmacol Ther. 2025. PMID: 39387234 Free PMC article.
Assessment of Dientamoeba fragilis interhuman transmission by fecal microbiota transplantation.
Moreno-Sabater A, Sintes R, Truong S, Lemoine K, Camou O, Kapel N, Magne D, Joly AC, Quelven-Bertin I, Alric L, Hennequin C, Sokol H; French Faecal Microbiota Transplant Group. Moreno-Sabater A, et al. Among authors: joly ac. Int J Antimicrob Agents. 2025 Aug;66(2):107504. doi: 10.1016/j.ijantimicag.2025.107504. Epub 2025 Apr 3. Int J Antimicrob Agents. 2025. PMID: 40187666
Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection Can Be the Best Therapeutic Option in Severely Immunocompromised Patients Depending on a Case-by-Case Assessment of the Benefit-to-Risk Ratio.
Benech N, Cassir N, Galperine T, Alric L, Scanzi J, Sokol H; French Fecal Transplant Group. Benech N, et al. Gastroenterology. 2024 Aug;167(3):627-628. doi: 10.1053/j.gastro.2024.04.022. Epub 2024 Apr 26. Gastroenterology. 2024. PMID: 38679396 No abstract available.
22 results